Asthma medication usage is significantly reduced following bariatric surgery.

dc.contributor.author

Guerron, Alfredo D

dc.contributor.author

Ortega, Camila B

dc.contributor.author

Lee, Hui-Jie

dc.contributor.author

Davalos, Gerardo

dc.contributor.author

Ingram, Jennifer

dc.contributor.author

Portenier, Dana

dc.date.accessioned

2022-07-01T15:11:48Z

dc.date.available

2022-07-01T15:11:48Z

dc.date.issued

2019-06

dc.date.updated

2022-07-01T15:11:47Z

dc.description.abstract

Introduction

Asthma is an important healthcare problem affecting millions in the United States. Additionally, a large proportion of patients with asthma suffer from obesity. These patients exhibit poor asthma control and reduced therapy response, increasing utilization of healthcare resources. Pulmonary symptoms improve after bariatric surgery (BS), and we hypothesized that asthma medication usage would decrease following BS.

Methods

A retrospective data analysis was performed in adult patients from a single institution's database. Patients with obesity using at least one asthma medication pre-operatively who underwent BS were studied for up to 3-years post-operation. Poisson generalized linear mixed models for repeated measures were used to evaluate the effects of time and procedure type on the number of asthma medication.

Results

Bariatric patients with at least one prescribed asthma medication (mean 1.4 ± 0.6) were included (n = 751). The mean age at time of operation was 46.8 ± 11.6 years, mean weight was 295.9 ± 57 lbs, and mean body mass index (BMI) was 49 ± 8.2 kg/m2; 87.7% were female, 33.4% had diabetes, 44.2% used gastroesophageal reflux disease (GERD) medication, and 64.4% used hypertension medication. The most common procedure was Roux-en-Y gastric bypass (79%), followed by sleeve gastrectomy (10.7%), adjustable gastric banding (8.1%), and duodenal switch (2.3%). The mean number of prescribed asthma medications among all procedures decreased by 27% at 30 days post-operation (p < 0.0001), 37% at 6 months (p < 0.0001), 44% at 1 year (p < 0.0001), and 46% at 3 years (p < 0.0001) after adjusting for risk factors. No significant differences in medication use over time between procedure types were observed. In the adjusted analysis, the mean number of asthma medications was 12% higher in patients using at least one GERD medication (p = 0.015) and 8% higher with 10-unit increase in pre-operative BMI (p = 0.006).

Conclusion

BS significantly decreases asthma medication use starting 30 days post-operation with a sustained reduction for up to 3 years.
dc.identifier

10.1007/s00464-018-6500-x

dc.identifier.issn

0930-2794

dc.identifier.issn

1432-2218

dc.identifier.uri

https://hdl.handle.net/10161/25441

dc.language

eng

dc.publisher

Springer Science and Business Media LLC

dc.relation.ispartof

Surgical endoscopy

dc.relation.isversionof

10.1007/s00464-018-6500-x

dc.subject

Humans

dc.subject

Asthma

dc.subject

Obesity, Morbid

dc.subject

Weight Loss

dc.subject

Anti-Asthmatic Agents

dc.subject

Body Mass Index

dc.subject

Retrospective Studies

dc.subject

Adult

dc.subject

Middle Aged

dc.subject

Female

dc.subject

Male

dc.subject

Bariatric Surgery

dc.title

Asthma medication usage is significantly reduced following bariatric surgery.

dc.type

Journal article

duke.contributor.orcid

Guerron, Alfredo D|0000-0002-4632-1681

duke.contributor.orcid

Ingram, Jennifer|0000-0002-5269-8864

pubs.begin-page

1967

pubs.end-page

1975

pubs.issue

6

pubs.organisational-group

Duke

pubs.organisational-group

School of Medicine

pubs.organisational-group

Faculty

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Medicine

pubs.organisational-group

Pathology

pubs.organisational-group

Surgery

pubs.organisational-group

Medicine, Pulmonary, Allergy, and Critical Care Medicine

pubs.organisational-group

Surgery, Metabolic and Weight Loss Surgery

pubs.organisational-group

Surgery, Surgical Sciences

pubs.publication-status

Published

pubs.volume

33

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Guerron2019_Article_AsthmaMedicationUsageIsSignifi.pdf
Size:
683.66 KB
Format:
Adobe Portable Document Format
Description:
Published version